Research ArticleOriginal Research

Increased Accuracy After Adjustment of Spirometry Threshold for Diagnosing COPD Based on Pre-Bronchodilator FEV1/FVC

Thomas Kronborg, Stine Hangaard, Simon Lebech Cichosz and Ole Hejlesen
Respiratory Care January 2019, 64 (1) 85-90; DOI: https://doi.org/10.4187/respcare.06148

References

  1. 1.↵
    Global Initiative for Chronic Obstructive Lung Disease. Pocket Guide to COPD Diagnosis, Management, and Prevention: A Guide for Health Care Professionals, 2017 edition. https://goldcopd.org/download/361/. Accessed August 3, 2018.
  2. 2.↵
    1. Bousquet J,
    2. Khaltaev N
    . Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. Geneva, Switzerland: World Health Organization; 2007: 1–146.
  3. 3.↵
    1. Lozano R,
    2. Naghavi M,
    3. Foreman K,
    4. Lim S,
    5. Shibuya K,
    6. Aboyans V,
    7. et al
    . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2095–2128.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Celli BR,
    2. Decramer M,
    3. Wedzicha JA,
    4. Wilson KC,
    5. Agustí A,
    6. Criner GJ,
    7. et al
    . An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2015;191(7):e4–e27.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Aggarwal AN,
    2. Gupta D,
    3. Agarwal R,
    4. Jindal SK
    . Comparison of the lower confidence limit to the fixed-percentage method for assessing airway obstruction in routine clinical practice. Respir Care 2011 56(11):1778–1784.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Cerveri I,
    2. Corsico AG,
    3. Accordini S,
    4. Niniano R,
    5. Ansaldo E,
    6. Antó JM,
    7. et al
    . Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax 2008;63(12):1040–1045.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Schermer TRJ,
    2. Smeele IJM,
    3. Thoonen BP,
    4. Lucas AEM,
    5. Grootens JG,
    6. van Boxem TJ,
    7. et al
    . Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care. Eur Respir J 2008;32(4):945–952.
    OpenUrlAbstract/FREE Full Text
  8. 8.
    1. Pistelli R,
    2. Ferrara L,
    3. Misuraca C,
    4. Bustacchini S
    . Practical management problems of stable chronic obstructive pulmonary disease in the elderly. Curr Opin Pulm Med 2011;17(Suppl 1):S43–S48.
    OpenUrlCrossRefPubMed
  9. 9.
    1. Brazzale DJ,
    2. Upward AL,
    3. Pretto JJ
    . Effects of changing reference values and definition of the normal range on interpretation of spirometry. Respirology 2010;15(7):1098–1103.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.
    1. Hansen JE,
    2. Sun XG,
    3. Wasserman K
    . Spirometric criteria for airway obstruction: use percentage of FEV1/FVC ratio below the fifth percentile, not <70%. Chest 2007;131(2):349–355.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.
    1. Hardie JA,
    2. Buist AS,
    3. Vollmer WM,
    4. Ellingsen I,
    5. Bakke PS,
    6. Mørkve O
    . Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002;20(5):1117–1122.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Hangaard S,
    2. Helle T,
    3. Nielsen C,
    4. Hejles
    . Causes of misdiagnosis of chronic obstructive pulmonary disease: a systematic scoping review. Respir Med 2017;129:63–84.
    OpenUrl
  13. 13.↵
    1. Güder G,
    2. Brenner S,
    3. Angermann CE,
    4. Ertl G,
    5. Held M,
    6. Sachs AP,
    7. et al
    . GOLD or lower limit of normal definition? A comparison with expert-based diagnosis of chronic obstructive pulmonary disease in a prospective cohort-study. Respir Res 2012;13(1):13.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Derom E,
    2. van Weel C,
    3. Liistro G,
    4. Buffels J,
    5. Schermer T,
    6. Lammers E,
    7. et al
    . Primary care spirometry. Eur Respir J 2008;31(1):197–203.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Arne M,
    2. Lisspers K,
    3. Ställberg B,
    4. Boman G,
    5. Hedenström H,
    6. Janson C,
    7. Emtner M
    . How often is diagnosis of COPD confirmed with spirometry? Respir Med 2010;104(4):550–556.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Miravitlles M,
    2. de la Roza C,
    3. Naberan K,
    4. Lamban M,
    5. Gobartt E,
    6. Martin A
    . Use of spirometry and patterns of prescribing in COPD in primary care. Respir Med 2007;101(8):1753–1760.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    National Center for Health Statistics. National Health and Nutrition Examination Survey. Atlanta, Georgia: Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/nhanes/. Accessed May 28, 2018.
  18. 18.↵
    National Center for Health Statistics. National Health and Nutrition Examination Survey. NHANES 2007-2008 examination data. Atlanta, Georgia: Centers for Disease Control and Prevention. https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Examination&CycleBeginYear=2007. Accessed May 28, 2018.
  19. 19.↵
    1. Raherison C,
    2. Girodet PO
    . Epidemiology of COPD. Eur Respir Rev 2009;18(114):213–221.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Knudson RJ,
    2. Slatin RC,
    3. Lebowitz MD,
    4. Burrows B
    . The maximal expiratory flow-volume curve normal standards, variability, and effects of age. Am Rev Respir Dis 1976;113(5):587–600.
    OpenUrlPubMedWeb of Science
  21. 21.↵
    1. Mannino DM,
    2. Diaz-Guzman E,
    3. Buist S
    . Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study. Respir Res 2011;12:136.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Mohamed Hoesein FAA,
    2. Zanen P,
    3. Sachs APE,
    4. Verheij TJM,
    5. Lammers JWJ,
    6. Broekhuizen BDL
    . Spirometric thresholds for diagnosing COPD: 0.70 or LLN, pre- or post-dilator values? COPD 2012;9(4):338–343.
    OpenUrlCrossRef
  23. 23.↵
    1. Johannessen A,
    2. Omenaas ER,
    3. Bakke PS,
    4. Gulsvik A
    . Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax 2005;60(10):842–847.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Waheed Z,
    2. Irfan M,
    3. Haque AS,
    4. Siddiqui NH,
    5. Awan S,
    6. Syed B,
    7. Khan JA
    . Assessing two spirometric criteria of pre-bronchodilator and post-bronchodilator FEV1/FVC ratio in detecting air flow obstruction. J Pak Med Assoc 2011;61(12):1172–1175.
    OpenUrlPubMed
  25. 25.↵
    1. Probst-Hensch NM,
    2. Curjuric I,
    3. Pierre-Olivier B,
    4. Ackermann-Liebrich U,
    5. Bettschart RW,
    6. Brändli O,
    7. et al
    . Longitudinal change of prebronchodilator spirometric obstruction and health outcomes: results from the SAPALDIA cohort. Thorax 2010;65(2):150–156.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Chen CZ,
    2. Ou CY,
    3. Wang WL,
    4. Lee CH,
    5. Lin CC,
    6. Chang HY,
    7. Hsiue TR
    . Using post-bronchodilator FEV1 is better than pre-bronchodilator FEV1 in evaluation of COPD severity. COPD 2012;9(3):276–280.
    OpenUrl
  27. 27.↵
    1. Fortis S,
    2. Eberlein M,
    3. Georgopoulos D,
    4. Comellas AP
    . Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes. BMJ Open Respir Res 2017;4(1):e000213.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Hwang YI,
    2. Kim CH,
    3. Kang HR,
    4. Shin T,
    5. Park SM,
    6. Jang SH,
    7. et al
    . Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria. J Korean Med Sci 2009;24(4):621–626.
    OpenUrlCrossRefPubMed
  29. 29.
    1. Lamprecht B,
    2. Schirnhofer L,
    3. Kaiser B,
    4. Buist SA,
    5. Mannino DM,
    6. Studnicka M
    . Subjects with discordant airways obstruction: lost between spirometric definitions of COPD. Pulm Med 2011;2011:780215.
    OpenUrlPubMed
  30. 30.
    1. Miller MR,
    2. Quanjer PH,
    3. Swanney MP,
    4. Ruppel G,
    5. Enright PL
    . Interpreting lung function data using 80% predicted and fixed thresholds misclassifies more than 20% of patients. Chest 2011;139(1):52–59.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.
    1. Vollmer WM,
    2. Gíslason T,
    3. Burney P,
    4. Enright PL,
    5. Gulsvik A,
    6. Kocabas A,
    7. Buist AS
    . Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study. Eur Respir J 2009;34(3):588–597.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Schermer TRJ,
    2. Quanjer PH
    . COPD screening in primary care: who is sick? Prim Care Respir J 2007;16(1):49–53.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Mohamed Hoesein FAA,
    2. Zanen P,
    3. Lammers JWJ
    . Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011;105(6):907–915.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2018 report. https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf. Accessed August 3, 2018.
  35. 35.↵
    1. Miller MR,
    2. Levy ML
    . Chronic obstructive pulmonary disease: missed diagnosis versus misdiagnosis. BMJ 2015;351:h3021.
    OpenUrlFREE Full Text
  36. 36.↵
    1. Hardin M,
    2. Cho M,
    3. McDonald ML,
    4. Beaty T,
    5. Ramsdell J,
    6. Bhatt S,
    7. et al
    . The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J 2014;44(2):341–350.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

 

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Related Articles

Cited By...

Keywords